Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neoadjuvant Immunochemotherapy for LAOSCC — Stella

Home/Oral Squamous Cell Carcinoma/Neoadjuvant Immunochemotherapy for LAOSCC

View on ClinicalTrials.gov

Recruiting

Back to Oral Squamous Cell Carcinoma trials

Neoadjuvant Immunochemotherapy for LAOSCC

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Huashan Hospital, Fudan University, Shanghai

Key details

Phase

Large-scale testing

Sponsor

Lai-ping Zhong

Collaborators

Sun Yat-sen University, Fudan University

Enrollment target

~134 participants

Started

February 2024

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.